Streetbeat News

Price Targets

CFR

Stephens & Co. analyst Matt Olney maintains an Equal-Weight rating on Cullen/Frost Bankers (NYSE:CFR) and lowers the price target from $121 to $117.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 28, 2023 | 4:10 pm

CVLG

Stephens & Co. analyst Jack Atkins maintains an Overweight rating on Covenant Logistics Gr (NASDAQ:CVLG) and raises the price target from $63 to $70.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 28, 2023 | 4:08 pm

BFST

Business First Bancshares reported better-than-expected Q2 financial results, leading to a rise in its stock price. Raymond James upgraded the stock from Market Perform to Outperform and set a $20 price target.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 4:05 pm

CX

JP Morgan has maintained an Overweight rating on Cemex's stock and increased its price target from $8 to $9. This has led to a rise in Cemex's share price.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 4:03 pm

RETA

Stifel analyst Annabel Samimy has downgraded Reata Pharmaceuticals from Buy to Hold, while raising the price target from $110 to $172.5.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 4:01 pm

LSTR

Stephens & Co. analyst Jack Atkins has maintained an Equal-Weight rating on Landstar System (NASDAQ:LSTR) and raised the price target from $200 to $210.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 28, 2023 | 3:58 pm

LYV

Live Nation Entertainment reported better-than-expected Q2 financial results, leading to a rise in its share prices. Several firms have also increased their price targets for the stock.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 3:58 pm

TCBX

Stephens & Co. analyst Matt Olney maintains an Overweight rating on Third Coast Bancshares (NASDAQ:TCBX) and raises the price target from $19 to $24.

Portfolio Pulse from jenniferd'souza@benzinga.com

July 28, 2023 | 3:56 pm

SQ

Exane BNP has upgraded Block's stock from Underperform to Outperform and set a new price target of $95. This has led to an increase in the trading of Block shares.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 3:55 pm

BMY

Wells Fargo analyst Mohit Bansal has maintained an Equal-Weight rating on Bristol-Myers Squibb (NYSE:BMY) and lowered the price target from $78 to $65.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 3:55 pm